Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study.
Martina SpazianteGloria TalianiGiulia MarchettiAlessandro TavelliMiriam LichtnerAntonella CingolaniStefania CicaliniElisa BiliottiEnrico GirardiAndrea AntinoriMassimo PuotiAntonella d'Arminio MonforteAlessandro Cozzi-LepriPublished in: Viruses (2021)
complex and rapid changes in TC and LDL-C levels, modulated by HCV genotype and PI/r-based ART combinations, occurred in HIV/HCV coinfected patients after SVR. Further studies are needed to evaluate the clinical impact of these changes on the long-term risk of cardiovascular disease.
Keyphrases
- hepatitis c virus
- human immunodeficiency virus
- cardiovascular disease
- end stage renal disease
- antiretroviral therapy
- ejection fraction
- hiv infected
- newly diagnosed
- hiv positive
- prognostic factors
- peritoneal dialysis
- type diabetes
- hiv testing
- machine learning
- metabolic syndrome
- south africa
- helicobacter pylori infection
- cardiovascular events
- fatty acid
- artificial intelligence
- cardiovascular risk factors
- data analysis